Nancy Lurker - Net Worth and Insider Trading
Nancy Lurker Net Worth
The estimated net worth of Nancy Lurker is at least $2 Million dollars as of 2024-11-29. Nancy Lurker is the Director of EyePoint Pharmaceuticals Inc and owns about 224,524 shares of EyePoint Pharmaceuticals Inc (EYPT) stock worth over $2 Million. Details can be seen in Nancy Lurker's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nancy Lurker has not made any transactions after 2024-08-16 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Nancy Lurker
Nancy Lurker Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Nancy Lurker owns 5 companies in total, including EyePoint Pharmaceuticals Inc (EYPT) , Aquestive Therapeutics Inc (AQST) , and Mallinckrodt PLC (MNKKQ) among others .
Click here to see the complete history of Nancy Lurker’s form 4 insider trades.
Insider Ownership Summary of Nancy Lurker
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
EYPT | EyePoint Pharmaceuticals Inc | 2024-08-16 | director & President and CEO |
AQST | Aquestive Therapeutics Inc | 2018-07-24 | director |
MNKKQ | Mallinckrodt PLC | 2013-06-28 | director |
2008-11-18 | CEO | ||
2013-06-28 | director |
Nancy Lurker Latest Holdings Summary
Nancy Lurker currently owns a total of 1 stock. Nancy Lurker owns 224,524 shares of EyePoint Pharmaceuticals Inc (EYPT) as of August 16, 2024, with a value of $2 Million.
Latest Holdings of Nancy Lurker
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
EYPT | EyePoint Pharmaceuticals Inc | 2024-08-16 | 224,524 | 9.05 | 2,031,942 |
Holding Weightings of Nancy Lurker
Nancy Lurker Form 4 Trading Tracker
According to the SEC Form 4 filings, Nancy Lurker has made a total of 5 transactions in EyePoint Pharmaceuticals Inc (EYPT) over the past 5 years, including 2 buys and 3 sells. The most-recent trade in EyePoint Pharmaceuticals Inc is the acquisition of 3,173 shares on August 16, 2024, which cost Nancy Lurker around $25,003.
Insider Trading History of Nancy Lurker
- 1
Nancy Lurker Trading Performance
GuruFocus tracks the stock performance after each of Nancy Lurker's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Nancy Lurker is -9.59%. GuruFocus also compares Nancy Lurker's trading performance to market benchmark return within the same time period. The performance of stocks bought by Nancy Lurker within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Nancy Lurker's insider trading performs compared to the benchmark.
Nancy Lurker Ownership Network
Nancy Lurker Owned Company Details
What does EyePoint Pharmaceuticals Inc do?
Who are the key executives at EyePoint Pharmaceuticals Inc?
Nancy Lurker is the director & President and CEO of EyePoint Pharmaceuticals Inc. Other key executives at EyePoint Pharmaceuticals Inc include SVP & Chief Commercial Officer David Scott Jones , Chief Medical Officer Dario A. Paggiarino , and Chief Corp Dev.&Strat. Officer Michael Craig Pine .
EyePoint Pharmaceuticals Inc (EYPT) Insider Trades Summary
Over the past 18 months, Nancy Lurker made 3 insider transaction in EyePoint Pharmaceuticals Inc (EYPT) with a net sale of 51,827. Other recent insider transactions involving EyePoint Pharmaceuticals Inc (EYPT) include a net sale of 943,936 shares made by Ew Healthcare Partners, L.p. , a net sale of 121,307 shares made by Dario A. Paggiarino , and a net purchase of 4,794,057 shares made by Cormorant Asset Management, Lp .
In summary, during the past 3 months, insiders sold 0 shares of EyePoint Pharmaceuticals Inc (EYPT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,229,811 shares of EyePoint Pharmaceuticals Inc (EYPT) were sold and 4,817,297 shares were bought by its insiders, resulting in a net purchase of 587,486 shares.
EyePoint Pharmaceuticals Inc (EYPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
EyePoint Pharmaceuticals Inc Insider Transactions
Nancy Lurker Mailing Address
Above is the net worth, insider trading, and ownership report for Nancy Lurker. You might contact Nancy Lurker via mailing address: Pdi, Inc., 1 Route 17 South, Saddle River Nj 07458.